Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
Clinical trial NCT02048722 · COMPLETED
Trial details
- NCT number
- NCT02048722
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-13
- Primary completion
- 2019-10-14
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.